BlackRock’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-33,779
| Closed | -$180K | – | 5438 |
|
|
2023
Q4 | $180K | Buy |
33,779
+2
| +0% | +$12 | ﹤0.01% | 4667 |
|
|
2023
Q3 | $270K | Sell |
33,777
-118
| -0.3% | -$701 | ﹤0.01% | 4592 |
|
|
2023
Q2 | $144K | Sell |
33,895
-198,055
| -85% | -$1.12M | ﹤0.01% | 4821 |
|
|
2023
Q1 | $1.31M | Buy |
231,950
+59,050
| +34% | +$449K | ﹤0.01% | 4239 |
|
|
2022
Q4 | $1.44M | Buy |
172,900
+4,935
| +3% | +$96.6K | ﹤0.01% | 4274 |
|
|
2022
Q3 | $5.41M | Sell |
167,965
-5,258
| -3% | -$195K | ﹤0.01% | 3720 |
|
|
2022
Q2 | $6.96M | Buy |
173,223
+139,681
| +416% | +$10.2M | ﹤0.01% | 3676 |
|
|
2022
Q1 | $3.59M | Buy |
33,542
+218
| +0.7% | +$34.2K | ﹤0.01% | 4128 |
|
|
2021
Q4 | $8.31M | Sell |
33,324
-4,176
| -11% | -$927K | ﹤0.01% | 3779 |
|
|
2021
Q3 | $7.35M | Hold |
37,500
| – | – | ﹤0.01% | 3810 |
|
|
2021
Q2 | $7.5M | Hold |
37,500
| – | – | ﹤0.01% | 3751 |
|
|
2021
Q1 | $7.61M | Hold |
37,500
| – | – | ﹤0.01% | 3729 |
|
|
2020
Q4 | $8M | Buy |
+37,500
| New | +$7.8M | ﹤0.01% | 3489 |
|
BlackRock's SNCE Position: Q1 2024 in Review
BlackRock sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 33,779 shares — an estimated $180K sold.
BlackRock first reported a position in SNCE in Q4 2020 and held it in 13 quarters. The position peaked at $8.31M in Q4 2021. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.
- BlackRock reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- BlackRock sold 33,779 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $180K.
- BlackRock first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2020 and held it in 13 quarters.
- BlackRock's Science 37 Holdings, Inc. Common Stock position peaked at $8.31M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.
Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.